Another biotech to add to our basket. I'm bullish on gild after a weak few months, 7x earnings excluding r&d with the fortress HIV providing most of cash flow.
Large cap with almost 100% upside
All the best.
Large cap with almost 100% upside
All the best.
코멘트:
on the move
코멘트:
Eyes here
